ARTICLE | Company News
Novavax, Laboratorios Farmaceuticos Rovi deal
July 6, 2009 7:00 AM UTC
Novavax agreed to license its recombinant virus-like particle (VLP) vaccine technology to Laboratorios Farmaceuticos to develop seasonal and pandemic influenza vaccines for the Spanish government unde...